| Ms Peggie A Smith, PA-C | |
|
75 Pringle Way Ste 401, Reno, NV 89502-1476 | |
| (775) 982-5000 | |
| (775) 982-2973 |
| Full Name | Ms Peggie A Smith |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 75 Pringle Way Ste 401, Reno, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053383331 | NPI | - | NPPES |
| 1053383331 | Medicaid | NV | |
| 12509167 | Other | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA1394 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Peggie A Smith, PA-C 850 Harvard Way, Reno, NV 89502-2055 Ph: (775) 982-5262 | Ms Peggie A Smith, PA-C 75 Pringle Way Ste 401, Reno, NV 89502-1476 Ph: (775) 982-5000 |
News Archive
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Computer models simulating the movement of pollen grains from trees in crowded areas could accelerate the spread of COVID-19.
A largescale study that included women from Germany and China has demonstrated a link between levels of traffic-related air pollution and air pollution-associated gases with the formation of dark spots on the skin, known as lentigenes. The most pronounced changes were observed on the cheeks of Asian women over the age of 50.
Optimer Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has issued U.S. Patent 7,906,489 which covers methods of Clostridium difficile infection treatment with fidaxomicin.
Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia (AML) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.
› Verified 4 days ago
Shaylee Nystrom, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5578 Longley Ln, Reno, NV 89511 Phone: 775-284-8650 | |
Logan Bode Howard, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 10635 Professional Cir Ste A, Reno, NV 89521 Phone: 775-852-0505 Fax: 775-852-0508 | |
Gretchen Goicoechea, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 75 Pringle Way, Suite 401, Reno, NV 89502 Phone: 775-688-8000 Fax: 775-688-8031 | |
Julio A Meza, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 7111 S Virginia St Ste D2, Reno, NV 89511 Phone: 775-870-1230 Fax: 833-606-1557 | |
Jonathan C Morgan, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 235 W 6th St, Reno, NV 89503 Phone: 775-746-3202 Fax: 775-746-1904 | |
Karie King, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 555 N Arlington Ave, Reno, NV 89503 Phone: 775-786-3040 Fax: 775-348-3051 | |
Cloe Jade Jeans, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5578 Longley Ln, Reno, NV 89511 Phone: 775-284-8650 |